logo
Select company
Select metric
$ -12.18MEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)
VS
Market
24
Sector
57
Industry
74
History
-
$ 5.31Close
$ 4.11 - $ 7.94 52-Week Range
Ticker Information

Ticker

SER

Company Name

SERINA THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NYSEMKT

SERINA THERAPEUTICS INC - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

SER - EBITDA Historical data
DateDepreciation, Amortization & AccretionEarning Before Interest & Taxes (EBIT)Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)
6/30/2025$ 372K$ -12.55M$ -12.18M
3/31/2025$ 429K$ -664K$ -235K
12/31/2024$ 421K$ -10.62M$ -10.19M
9/30/2024$ 476.37K$ 9.78M$ 10.26M
6/30/2024$ 395.37K$ 5.99M$ 6.39M
3/31/2024$ 299.37K$ -1.33M$ -1.03M
12/31/2023$ 131K$ -9.9M$ -9.77M
9/30/2023$ 131K$ -8.14M$ -8.01M
6/30/2023$ 131K$ -7.29M$ -7.16M
3/31/2023$ 132K$ -7.17M$ -7.04M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • SERINA THERAPEUTICS INC's latest trailing twelve months (TTM) EBITDA stands at $ -9.43M.
  • Over the past 5 years, SERINA THERAPEUTICS INC's average EBITDA has been $ -5.85M.
  • The median EBITDA for SERINA THERAPEUTICS INC during this period was $ -7.44M
  • SERINA THERAPEUTICS INC reached its highest EBITDA over the past 5 years at $ 10.26M.
  • The lowest EBITDA recorded by SERINA THERAPEUTICS INC in the same timeframe $ -12.18M

SERINA THERAPEUTICS INC's EBITDA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA Benchmarks
CompanyEBITDA
MNOV : MEDICINOVA INC $ -11.61MAPLT : APPLIED THERAPEUTICS INC $ -67.34MSABS : SAB BIOTHERAPEUTICS INC $ -33.47MENTX : ENTERA BIO LTD $ -10.55MHYPD : HYPERION DEFI INC $ -37.04MINO : INOVIO PHARMACEUTICALS INC $ -84.73MGUTS : FRACTYL HEALTH INC $ -97.26MAIM : AIM IMMUNOTECH INC $ -14.93MVTVT : VTV THERAPEUTICS INC $ -19.5MABP : ABPRO HOLDINGS INC $ -10.56M

Similar metrics to EBITDA:

Definition of Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

[Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].
EBIT + DepAmor
(=) EBITDA EBITDA for SERINA THERAPEUTICS INC is calculated as follows: EBIT [ $ -10.82M ] + DepAmor [ $ 1.4M ]
(=) EBITDA [ $ -9.43M ]

SER - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA), Last 5 years

$ -12.18M

Minimum

Jun 30, 2025

$ 10.26M

Maximum

Sep 30, 2024

$ -5.85M

Average

$ -7.44M

Median

EBITDA Benchmark Analysis

 The chart above depicts the distribution of EBITDA for companies in the Total Stock Market. The average EBITDA of the companies is $ 58.9M with a standard deviation of $ 167.01M.
The following table provides additional summary stats:
EBITDA in the Market:
filtered constituents3.24K
min$ -493.3M
max$ 590.6M
average$ 58.9M
median$ 8.92M
std$ 167.01M